Advanced Cell Technology Appoints Edward Myles as Chief Financial Officer
5/23/2013 7:57:03 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Advanced Cell Technology, Inc. (“ACT”; OTCQB: ACTC), a leader in the field of regenerative medicine, today announced the appointment of Edward “Ted” Myles, CPA, as Chief Financial Officer and Executive Vice President of Corporate Development. Myles joins the Company with nearly 20 years of progressive finance and operations experience in the life sciences industry.
Help employers find you! Check out all the jobs and post your resume.
comments powered by